HR 7352
  • Introduced
    Feb 04, 2026
  • Passed House
  • Passed Senate
  • Became Law
HR 7352
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.
Last Action See all actions
House • Feb 04, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summary

Comments on HR 7352

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Feb 04, 2026 | House
    • Introduced in House
    • Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources